Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

Background Platelets are involved in inflammatory reactions which play an important role in the development of atherosclerosis and its acute complications. The objective of this study was to test the ability of glycoprotein (GP) IIb-IIIa antagonist eptifibatide to suppress the increase of inflammato...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2009-02, Vol.27 (2), p.146-153
Hauptverfasser:	Mazaev, Alexey A., Naimushin, Yaroslav A., Masenko, Valery P., Ruda, Mikhail Y., Mazurov, Alexey V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - pathology Adult Angina Pectoris Biomarkers - blood Cardiology Case-Control Studies Electrocardiography Female Hematology Humans Inflammation - drug therapy Inflammation - etiology Male Medicine Medicine & Public Health Middle Aged Peptides - pharmacology Peptides - therapeutic use Platelet Aggregation Inhibitors - pharmacology Platelet Aggregation Inhibitors - therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!